/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.07%
Natural Gas
-0.18%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.32%
VIX
N/A
Economic Calendar
EUR/USD
+0.07%
Natural Gas
-0.18%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.32%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
October Retail Sales Rise 0.4%, Show Resilience Despite Slowing Momentum
3 days ago
China Retail Sales Jumps in October as Unemployment Drops to 5.0%
3 days ago
France’s Economic Strengths Balance Increasingly Challenging Fiscal, Political Outlooks
3 days ago
Crude Inventories Rise By 2.1 Million Barrels, Exceeding Analyst Estimates
4 days ago
October PPI Rises 0.2%, Supporting Fed Rate Cut Hopes as Inflation and Jobs Steady
4 days ago
Disney’s Streaming Fuels Optimism; PPI Data May Forecast Fed’s Next Steps
4 days ago
Dax Index News: ECB Commentary, Trade Data to Fuel DAX Price Action
34 minutes ago
Hang Seng Index Leads Asian Markets as Nikkei 225 Stumbles on Rate Jitters
about 2 hours ago
XRP News Today: BlackRock ETF Could Propel XRP to ATH as BTC Eyes $100k
about 3 hours ago
Gold, Bond Yield, US Dollar Technical Analysis: Market Consolidation as Uncertainty Looms
about 5 hours ago
Japanese Yen and Australian Dollar News: BoJ Governor Ueda Set to Impact USD/JPY
about 7 hours ago
Week Ahead: Bitcoin to $100K And Ethereum’s Underperformance in Focus
about 8 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
NAMS
NewAmsterdam Pharma Company NV
Follow
NAMS
(
Nasdaq - US
)
Closed
24.93
-0.04 (-0.16%)
in
:
usd
•
As of: Nov 15, 2024 15:59
UTC -5
Open
24.70
High
25.12
Low
24.50
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Stats
Prev. Close
24.97
Open
24.70
Day's Range
24.50 - 25.12
52 Week Range
8.90 - 26.35
YTD Change
123.19%
1 Year Change
163.81%
Market Cap
2.30B
P/E Ratio
N/A
Volume
17,240
Beta
-0.01
Sector
Health Technology
Industry
Pharmaceuticals Major
Economic Calendar
All Events
Time zone
:
GMT
Friday, November 15th 2024
Time
Currency
Event
Impact
Actual
Consensus
Previous
13:30
USD
Retail Sales MoM
Oct
High
0.4%
0.3%
0.8%
14:15
USD
Industrial Production MoM
Oct
Medium
-0.3%
-0.3%
-0.5%
15:00
USD
Business Inventories MoM
Sep
Medium
0.1%
0.2%
0.3%
Saturday, November 16th 2024
Time
Currency
Event
Impact
Actual
Consensus
Previous
16:55
USD
Fed Collins Speech
Medium
Monday, November 18th 2024
Time
Currency
Event
Impact
Actual
Consensus
Previous
15:00
USD
NAHB Housing Market Index
Nov
Medium
44
43
15:00
USD
Fed Goolsbee Speech
Medium
21:00
USD
Net Long-term TIC Flows
Sep
Medium
$114.3B
$111.4B
Latest News
Seeking Alpha
Oct 4, 2024
Obicetrapib Positions NewAmsterdam Pharma For Significant Market Growth In Cardiovascular Therapies
NAMS
-0.16%
Benzinga
Aug 28, 2024
NewAmsterdam Pharma's Cholesterol Drug To See Blockbuster Sales, Bullish Analyst Sees Massive Upside
NAMS
-0.16%
Investors Business Daily
Jul 29, 2024
NewAmsterdam Touts Cholesterol Drug Success, But Results Trail Analysts' Expectations
NAMS
-0.16%
Seeking Alpha
Jul 5, 2024
NewAmsterdam Pharma: Cholesterol Drug Treatment With Catalysts In 1-Year Period
NAMS
-0.16%
Zacks Investment Research
Mar 13, 2024
NewAmsterdam (NAMS) Doses Patient in HeFH Study, Shares Up
Seeking Alpha
Oct 3, 2023
NewAmsterdam Pharma's Pioneering Pulse On Alzheimer's Breakthroughs
Read All
Data Vendor
:
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker